FGF21 and heart failure: There are some promising novel biomarkers, such as galectin-3, ST2, FGF-21, IGFBP-7, GDF-15, and TGF-β, that provide good specificity in diagnosing diastolic dysfunction or overt heart failure in diabetic patients.